Background: With the development of globalization, the rising cost of clinical trials in Europe and the United States, and the huge drug consumption market in developing countries, multinational pharmaceutical giants have set their sights on emerging developing countries. As a leader in developing countries, China has unparalleled advantages, so more and more clinical trials are registered and carried out in China. Objective: The objective of the study is to understand the current practice of informed consent in clinical trials in public hospitals in Xuzhou. Methods: In this study, a 15-question questionnaire was distributed to 369 subjects in the affiliated hospital of Xuzhou medical university. Each question was graded on a 3-point scale (1 = no, 2 = unsure, 3 = yes). The sum of the scores for the 15 questions represented the level of awareness of clinical trials. Results: Valid questionnaires were received from 300 subjects. A considerable number of subjects still had insufficient understanding of clinical trials, especially concerning the nature of clinical trials, understanding of informed consent forms, contact with researchers, and ethics committee. (The “yes” rate was around or below 50%). Factors associated with responses to the survey include education, occupation, and source of medical expenses. Conclusion: Overall, this study showed that the implementation of informed consent in China remained room for improvement. Legislators, ethics officers, and researchers should work together to protect the interests of subjects.
Harmer, A., Xiao, Y., Missoni, E. and Tediosi, F. (2013) ‘BRICS without Straw’? A Systematic Literature Review of Newly Emerging Economies’ Influence in Global Health. Globalization and Health, 9, Article No. 15. https://doi.org/10.1186/1744-8603-9-15
Chakma, J., Sun, G.H., Steinberg, J.D., Sammut, S.M. and Jagsi, R. (2014) Asia’s Ascent—Global Trends in Biomedical R&D Expenditures. New England Journal of Medicine, 370, 3-6. https://doi.org/10.1056/NEJMp1311068
Behrendt, C., Gölz, T., Roesler, C., Bertz, H. and Wünsch, A. (2011) What Do Our Patients Understand about Their Trial Participation? Assessing Patients’ Understanding of Their Informed Consent Consultation about Randomised Clinical Trials. Journal of Medical Ethics, 37, 74-80. https://doi.org/10.1136/jme.2010.035485
Nijhawan, L.P., Janodia, M.D., Muddukrishna, B.S., Bhat, K.M., Bairy, K.L., et al. (2013) Informed Consent: Issues and Challenges. Journal of Advanced Pharmaceutical Technology & Research, 4, 134-140. https://doi.org/10.4103/2231-4040.116779
Brown, R.F., Butow, P.N., Butt, D.G., Moore, A.R. and Tattersall, M.H. (2004) Developing Ethical Strategies to Assist Oncologists in Seeking Informed Consent to Cancer Clinical Trials. Social Science & Medicine, 58, 379-390. https://doi.org/10.1016/S0277-9536(03)00204-1
Alexa-Stratulat, T., Neagu, M., Neagu, A.I., Alexa, I.D. and Ioan, B.G. (2018) Consent for Participating in Clinical Trials—Is It Really Informed? Developing World Bioethics, 18, 299-306. https://doi.org/10.1111/dewb.12199
Vallotton, M.B. (2010) Council for International Organizations of Medical Sciences Perspectives: Protecting Persons through International Ethics Guidelines. International Journal of Integrated Care, 10, 5. https://doi.org/10.5334/ijic.478
General Assembly of the World Medical Association (2014) World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. The Journal of the American College of Dentists, 81, 14-18. https://pubmed.ncbi.nlm.nih.gov/25951678/
Guideline, I.H.T. (2001) Guideline for Good Clinical Practice. http://www.onlinegcp.de/Lessons/GCP/Doc/ICH-GCP%20Guideline.pdf
Will, J.F. (2011) A Brief Historical and Theoretical Perspective on Patient Autonomy and Medical Decision Making. Part I: The Beneficence Model. Chest Journal, 139, 669-673. https://doi.org/10.1378/chest.10-2532
Raposo, V.L. (2019) Lost in ‘Culturation’: Medical Informed Consent in China (from a Western Perspective). Medicine, Health Care and Philosophy, 22, 17-30. https://doi.org/10.1007/s11019-018-9835-0
Dai, Q. (2003) Informed Consent in China: Status Quo and Its Future. Medical Law International, 6, 53-71. https://doi.org/10.1177/096853320300600104
Flory, J. and Emanuel, E. (2004) Interventions to Improve Research Participants’ Understanding in Informed Consent for Research: A Systematic Review. JAMA, 292, 1593-1601. https://doi.org/10.1001/jama.292.13.1593
Joffe, S., Cook, E.F., Cleary, P.D., Clark, J.W. and Weeks, J.C. (2001) Quality of Informed Consent in Cancer Clinical Trials: A Cross-Sectional Survey. The Lancet, 358, 1772-1777. https://doi.org/10.1016/S0140-6736(01)06805-2
Daugherty, C., Ratain, M.J., Grochowski, E., Stocking, C., Kodish, E., Mick, R., et al. (1995) Perceptions of Cancer Patients and Their Physicians Involved in Phase I Trials. Journal of Clinical Oncology, 13, 1062-1072. https://doi.org/10.1200/JCO.1995.13.5.1062
Meropol, N.J., Weinfurt, K.P., Burnett, C.B., Balshem, A., Benson III, A.B., Castel, L., et al. (2003) Perceptions of Patients and Physicians regarding Phase I Cancer Clinical Trials: Implications for Physician-Patient Communication. Journal of Clinical Oncology, 21, 2589-2596. https://doi.org/10.1200/JCO.2003.10.072
Griffin, J.M., Struve, J.K., Collins, D., Liu, A., Nelson, D.B., et al. (2006) Long Term Clinical Trials: How Much Information Do Participants Retain from the Informed Consent Process? Contemporary Clinical Trials, 27, 441-448. https://doi.org/10.1016/j.cct.2006.04.006
Wen, G., Liu, X., Huang, L., Shu, J., Xu, N., Chen, R., et al. (2016) Readability and Content Assessment of Informed Consent Forms for Phase II-IV Clinical Trials in China. PLoS ONE, 11, e0164251. https://doi.org/10.1371/journal.pone.0164251
Taylor, H.A. (1999) Barriers to Informed Consent. Seminars in Oncology Nursing, 15, 89-95. https://doi.org/10.1016/S0749-2081(99)80066-7
Jianping, W., Li, L., Xue, D., Tang, Z., Jia, X., Wu, R., et al. (2010) Analysis of the Status of Informed Consent in Medical Research Involving Human Subjects in Public Hospitals in Shanghai. Journal of Medical Ethics, 36, 415-419. https://doi.org/10.1136/jme.2009.034629
Shen, H., Teng, F. and Song, J. (2018) Evaluation of Spatial Balance of China’s Regional Development. Sustainability, 10, Article No. 3314. https://doi.org/10.3390/su10093314
Das, D., Cheah, P.Y., Akter, F., Paul, D., Islam, A., Sayeed, A.A., et al. (2014) Participants’ Perceptions and Understanding of a Malaria Clinical Trial in Bangladesh. Malaria Journal, 13, Article No. 217. https://doi.org/10.1186/1475-2875-13-217
Denicoff, A.M., McCaskill-Stevens, W., Grubbs, S.S., Bruinooge, S.S., Comis, R.L., Devine, P., et al. (2013) The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: Summary and Recommendations. Journal of Oncology Practice, 9, 267-276. https://doi.org/10.1200/JOP.2013.001119
Wu, E., Wang, T., Lin, T., Chen, X., Guan, Z., Cao, C., et al. (2015) A Comparative Study of Patients’ Attitudes toward Clinical Research in the United States and Urban and Rural China. Clinical and Translational Science, 8, 123-131. https://doi.org/10.1111/cts.12254
Comis, R.L., Miller, J.D., Colaizzi, D.D. and Kimmel, L.G. (2009) Physician-Related Factors Involved in Patient Decisions to Enroll onto Cancer Clinical Trials. Journal of Oncology Practice, 5, 50-56. https://doi.org/10.1200/JOP.0922001
Lee, S.C. (2015) Intimacy and Family Consent: A Confucian Ideal. Journal of Medicine and Philosophy, 40, 418-436. https://doi.org/10.1093/jmp/jhv015
Pratt, B., Van, C., Cong, Y., Rashid, H., Kumar, N., Ahmad, A., et al. (2014) Perspectives from South and East Asia on Clinical and Research Ethics: A Literature Review. Journal of Empirical Research on Human Research Ethics, 9, 52-67. https://doi.org/10.1525/jer.2014.9.2.52
Gong, N., Zhou, Y., Cheng, Y., Chen, X., Li, X., Wang, X., et al. (2018) Practice of Informed Consent in Guangdong, China: A Qualitative Study from the Perspective of In-Hospital Patients. BMJ Open, 8, e020658. https://doi.org/10.1136/bmjopen-2017-020658